Superworth

Cibus revenue CBUS

Sales by quarter and over the last twelve months, from 2016.

Last 12 months, to Jun 30, 2026
$4.3M
Latest quarter, Q2 FY26
$994K
+7% on a year earlier
Fiscal year 2025
$3.6M
−15% on the year before

Cibus' revenue was $4.3M over the twelve months to Jun 30, 2026, down 10% on a year earlier.

In its latest quarter, Q2 FY26, it was $994K, up 7% on the same quarter a year before.

Over the five fiscal years to FY2025 it shrank 31% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2025$3.6M−15%
FY2024$4.3M+135%
FY2023$1.8M+1057%
FY2022$157K−99%
FY2021$26M+9%
FY2020$23.9M+227%
FY2019$7.3M+2992%
FY2018$236K−54%
FY2017$508K+27%
FY2016$399Kn/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q2 FY26$994K+7%$4.3M
Q1 FY26$1.7M+63%$4.3M
Q4 FY25$1.1M−13%$3.6M
Q3 FY25$615K−63%$3.8M
Q2 FY25$933K+11%$4.8M
Q1 FY25$1M+90%$4.8M
Q4 FY24$1.2M+10%$4.3M
Q3 FY24$1.7M+251%$4.2M
Q2 FY24$838K+325%$3M
Q1 FY24$545K+1198%$2.3M
Q4 FY23$1.1M+2526%$1.8M
Q3 FY23$475K+1031%$756K

Against its peers

Companies in Basic Materials nearest Cibus' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
CBUSCibus$4.3M−10% a year
SMIDSmith Midland$89.5M−2% a year
FTLFFitlife Brands$101.3M+61% a year
BWENBroadwind$140.3M+17% a year
NAGENiagen Bioscience$129.1M+11% a year
SNDSmart Sand$387M+27% a year
ALTOAlto Ingredients$943.3M+1% a year
FRDFriedman Industries$752.1M+62% a year
BTMDbiote$183.5M−8% a year
IDRIdaho Strategic Resources$50.9M+67% a year
VFFVillage Farms International$230.6M−3% a year
Peer median$161.9M

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Cibus

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.